IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats
2007

IL-23 and Osteoclast Formation in Arthritis

Sample size: 28 publication 10 minutes Evidence: moderate

Author Information

Author(s): Yago Toru, Nanke Yuki, Kawamoto Manabu, Furuya Takefumi, Kobashigawa Tsuyoshi, Kamatani Naoyuki, Kotake Shigeru

Primary Institution: Institute of Rheumatology, Tokyo Women's Medical University

Hypothesis

IL-23 stimulates human osteoclastogenesis via IL-17 and can be targeted to treat collagen-induced arthritis.

Conclusion

The study shows that IL-23 is crucial for osteoclast formation and that blocking IL-23 can reduce inflammation and bone destruction in arthritis.

Supporting Evidence

  • IL-23 directly induces osteoclastogenesis from human PBMC.
  • Anti-IL-23 antibody treatment reduced paw volume in rats with collagen-induced arthritis.
  • The study found that IL-17 and TNF-alpha are involved in IL-23-induced osteoclastogenesis.

Takeaway

IL-23 helps make cells that break down bone, and stopping it can help treat arthritis.

Methodology

The study involved culturing human peripheral blood mononuclear cells with IL-23 and assessing osteoclast formation, as well as treating rats with anti-IL-23 antibody to evaluate its effects on arthritis.

Potential Biases

Potential bias in the selection of animal models and the interpretation of results.

Limitations

The study had a small sample size and the effects of different dosages of anti-IL-23 antibody were not fully explored.

Participant Demographics

Healthy volunteers provided blood samples for the in vitro studies.

Statistical Information

P-Value

0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/ar2297

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication